Skip to main content
DNA Labs India

Oncomine Lung cfTNA Cancer Panel Test

DNA Labs India | ISO 9001:2015 Certified

Oncomine Lung cfTNA Cancer Panel Test

Short Name: Lung cfTNA Cancer Panel

Also known as: cfTNA Lung Panel, Circulating Tumor DNA Lung Cancer Panel, Oncomine cfTNA Panel

Oncomine Lung cfTNA Cancer Panel Test test available at DNA Labs India for ₹52,500. Uses Next-Generation Sequencing (NGS) on Peripheral blood samples. Results in 2-3 weeks from sample collection. Free home collection in 300+ cities across India.

Molecular DiagnosticsAdults🏠 Home Collection

🩺 Medically Reviewed By

Overview

To detect lung cancer-related genetic mutations in circulating tumor DNA (ctDNA) from blood, aiding in early diagnosis, treatment selection, and monitoring without invasive procedures.

Test Code
3131
Price
₹52,500
Sample Type
Peripheral blood
Result Time
2-3 weeks from sample collection
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation required. Ensure a doctor's prescription is available if needed. Inform the healthcare provider about any medications or recent treatments.

Method: Venipuncture

Step 2

Laboratory Analysis

A blood sample of 10 ml will be drawn from a vein in the arm using standard venipuncture techniques. The process is quick and minimally invasive.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bleeding. Resume normal activities immediately. Results will be communicated via the chosen delivery method.

Timeline: 2-3 weeks from sample collection

Patient Instructions

1
Before the Test:Obtain a doctor's prescription if required. No fasting is needed. Stay hydrated and wear comfortable clothing for blood draw.
2
During the Test:The test involves a simple blood draw. A healthcare professional will collect 10 ml of blood from your arm vein. The procedure takes about 10-15 minutes.
3
After the Test:You can resume normal activities immediately. Monitor the puncture site for any bruising. Results will be available in 2-3 weeks.

About This Test

Who Should Get This Test

To detect lung cancer-related genetic mutations in circulating tumor DNA (ctDNA) from blood, aiding in early diagnosis, treatment selection, and monitoring without invasive procedures.

How to Prepare

  • Ensure the patient is relaxed and hydrated
  • Use aseptic technique to avoid contamination
  • Label the sample correctly with patient details
  • Transport the sample to the lab within 24 hours at ambient temperature

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"This non-invasive panel is crucial for early detection and personalized treatment planning in lung cancer, offering high accuracy without the need for tissue biopsy."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypePeripheral blood
Sample Volume10 ml
ContainerEDTA tube
Collection MethodVenipuncture

Sample Stability

Stable for 24 hours at room temperature (15-30°C)
Can be refrigerated at 2-8°C for up to 48 hours
Sample Rejection Criteria:
  • Insufficient sample volume
  • Improperly labeled or hemolyzed samples
  • Sample received beyond stability period

Understanding Your Results

Results indicate the presence or absence of specific genetic mutations in ctDNA. Positive results suggest lung cancer-associated mutations, guiding treatment decisions. Negative results do not entirely rule out cancer and should be correlated with clinical findings.
Positive for mutations: Consult an oncologist for targeted therapy options
Negative for mutations: Consider additional diagnostic tests if symptoms persist
Variant of uncertain significance (VUS): May require further investigation or genetic counseling
⚠️ When to Consult a Doctor:

Consult a healthcare professional immediately if you experience symptoms like persistent cough, chest pain, or weight loss. After receiving test results, discuss them with an oncologist for personalized management.

Limitations

  • May not detect all genetic variants or low-frequency mutations
  • False negatives possible if tumor shedding is minimal
  • Not a standalone diagnostic; should be used with clinical evaluation and imaging

Risks & Considerations

  • Minimal risk from blood draw, such as slight pain, bruising, or infection at the puncture site

Interfering Factors

  • Hemolyzed or lipemic blood samples
  • Low tumor DNA yield due to early-stage cancer
  • Recent chemotherapy or radiation therapy affecting ctDNA levels

Compare With Similar Tests

TestOncomine Lung cfTNA Cancer PanelTissue BiopsyCT ScanSputum CytologyPET Scan
ComparisonOncomine Lung cfTNA Cancer Panel

Frequently Asked Questions

What is the Oncomine Lung cfTNA Cancer Panel?
It is a non-invasive blood test that analyzes circulating tumor DNA (ctDNA) to detect genetic mutations associated with lung cancer.
How is the test performed?
A blood sample is drawn from your arm, and ctDNA is extracted and analyzed using Next-Generation Sequencing (NGS) technology.
What is the cost of this test in India?
The cost is INR 52,500, which includes home sample collection and report delivery.
Is the test painful?
No, it involves a standard blood draw, which may cause minimal discomfort similar to any blood test.
How accurate is the Oncomine Lung cfTNA Cancer Panel?
The test has high sensitivity and specificity, but accuracy can vary based on tumor DNA shedding. It should be used alongside other diagnostics.
Who should take this test?
Individuals with symptoms of lung cancer, such as persistent cough or chest pain, or those at high risk due to smoking or family history.
Is fasting required before the test?
No, fasting is not required. You can eat and drink normally before the test.
How long does it take to get results?
Results are typically available within 2-3 weeks after sample collection.
Is the test covered by insurance?
Yes, most health insurance plans in India cover this test. Check with your insurer for specific details.
Can this test replace a biopsy?
No, it is a complementary tool. A biopsy may still be needed for definitive diagnosis in some cases.
What do positive results mean?
Positive results indicate the presence of lung cancer-associated mutations, which can guide targeted therapy options.
Are there any risks associated with the test?
The risks are minimal, limited to those of a standard blood draw, such as bruising or infection at the puncture site.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.